Want to see UAMY full AI Analyst Report?
Top Page
United States Antimony
(NYSE:UAMY)
Select Model
Select Model
Rating:50Neutral
Price Target:
$3.00
▼(-42.31% Downside)
Action:Reiterated
Date:10/26/26
UAMY scores in the lower-middle range primarily due to weak TTM profitability and especially heavy cash burn, which outweigh the strong, low-leverage balance sheet. Technicals also detract, with the stock in a clear downtrend despite near-oversold momentum readings. Offsetting factors include constructive earnings-call progress on the DLA contract and strong liquidity, plus supportive corporate actions (notably the buyback authorization), but near-term results remain highly sensitive to antimony pricing and execution/timing.
Positive Factors
DLA contract execution
The large sole-source DLA award provides a multi-period demand opportunity in a strategically important market. Initial deliveries demonstrate execution progress, while additional orders and shipments could improve production utilization, revenue visibility, and customer diversification over the next several quarters.
Negative Factors
Severe profitability pressure
Very thin gross margins and a deep net loss show that current revenue scale is not translating into adequate earnings. Persistently weak profitability could limit internally funded growth, make operating improvements more important, and reduce the durability of returns on the company’s large capital base.
Read all positive and negative factors
Positive Factors
Negative Factors
DLA contract execution
The large sole-source DLA award provides a multi-period demand opportunity in a strategically important market. Initial deliveries demonstrate execution progress, while additional orders and shipments could improve production utilization, revenue visibility, and customer diversification over the next several quarters.
Read all positive factors
United States Antimony (UAMY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$426.56M
Dividend YieldN/A
Average Volume (3M)5.70M
Price to Earnings (P/E)―
Beta (1Y)2.19
Revenue Growth35.89%
EPS Growth-1309.41%
CountryUS
Employees101
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)-0.12
Shares Outstanding149,669,390
10 Day Avg. Volume7,463,660
30 Day Avg. Volume5,701,904
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)4.40
Price to Sales (P/S)15.81
P/FCF Ratio-16.55
Enterprise Value/Market Cap2.48
Enterprise Value/Revenue28.98
Enterprise Value/Gross Profit2.21K
Enterprise Value/Ebitda-58.14
Forecast
1Y Price Target
$9.38Price Target Upside80.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.07
Revenue Forecast (FY)$64.72M
United States Antimony Business Overview & Revenue Model
Company Description
United States Antimony Corporation produces and sells antimony, zeolite, and precious metals in the United States and Canada. It operates in two segments: Antimony and Zeolite. The company offers antimony trioxide that is primarily used in conjunc...
How the Company Makes Money
UAMY primarily makes money by selling antimony-based products—principally antimony metal (e.g., ingots) and antimony oxide—into industrial end markets. Revenue is generated when the company (1) sources antimony-bearing material (from its own minin...
United States Antimony Earnings Call Summary
Earnings Call Date:Aug 11, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 18, 2026
Earnings Call Sentiment Positive
The call highlights clear operational progress: initial DLA shipments, meaningful liquidity ($62.2M total liquidity), rapid zeolite growth (+110% revenue YoY), expanded institutional ownership (>57%), and active mine development across multiple properties. However, financial results are meaningfully impacted by a sharp decline in realized antimony prices (average selling price down ~52% YoY), leading to significant margin compression, higher operating losses (driven in part by increased noncash share-based compensation), and timing delays in recognizing DLA revenue. The company’s strong balance sheet, ongoing deliveries under a $245M DLA contract, and operational milestones outweigh the near-term revenue and margin pressures driven by weak commodity prices and some timing/operational risks.Positive Updates
Strong Liquidity Position
Cash and cash equivalents of $41.4M at June 30, 2026 (up from $3.2M at March 31, 2026) plus $20.7M in U.S. Treasuries for total liquidity of $62.2M; total cash investments and marketable securities of $105M including a $43.2M strategic equity investment.
Negative Updates
Year-over-Year Revenue Decline Driven by Antimony Prices
Q2 2026 revenue was $7.9M, down ~25% YoY from $10.5M; six-month revenue $14.7M vs $17.5M prior year (down ~16%), primarily due to lower realized antimony prices.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Liquidity Position
Cash and cash equivalents of $41.4M at June 30, 2026 (up from $3.2M at March 31, 2026) plus $20.7M in U.S. Treasuries for total liquidity of $62.2M; total cash investments and marketable securities of $105M including a $43.2M strategic equity investment.
Read all positive updates
Company Guidance
Management lowered full‑year revenue guidance to $60–$75 million, attributing the cut to weaker antimony prices even as the company advances a $245 million sole‑source DLA contract (cumulative DLA orders ≈ $57.3M); USAC delivered the first two DLA shipments (~82,000 pounds) in June (~$2.6M), expects two more truckloads to add ~ $2.6M in Q3, and truckloads 5–7 (>120,000 pounds) to contribute ≈ $4M in Q4 (pending testing/acceptance), which management says should drive margin expansion in Q3–Q4. Recent operating and balance‑sheet metrics: Q2 revenue $7.9M (H1 $14.7M); Q2 antimony revenue $5.9M with pounds sold up ~26% YoY to ≈428k; average selling price down ~52% YoY to $13.70/ lb (average cost down ~33% to $13.34/ lb); zeolite revenue +110% to $1.9M (tons +114%); Q2 gross profit $0.6M (7% margin) and operating loss ≈$7M (including ~$3.4M noncash items); cash $41.4M, US Treasuries $20.7M (total liquidity $62.2M), inventory $21.6M, working capital $70M, total assets $191M, and total liabilities $9.6M.United States Antimony Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
78
Positive
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.44M | 39.26M | 14.94M | 8.69M | 11.04M | 7.75M |
| Gross Profit | 477.21K | -1.71M | 3.47M | -3.34M | 2.00M | 838.61K |
| EBITDA | -18.16M | -3.17M | -1.29M | -5.89M | 1.37M | 825.95K |
| Net Income | -16.25M | -4.34M | -1.73M | -6.35M | 428.66K | -60.47K |
Balance Sheet | ||||||
| Total Assets | 190.62M | 153.93M | 34.64M | 28.09M | 34.70M | 35.00M |
| Cash, Cash Equivalents and Short-Term Investments | 46.10M | 30.49M | 18.17M | 11.97M | 19.32M | 21.62M |
| Total Debt | 364.08K | 185.05K | 1.71M | 28.44K | 312.00K | 215.15K |
| Total Liabilities | 9.59M | 12.97M | 6.04M | 2.57M | 2.83M | 2.63M |
| Stockholders Equity | 181.02M | 140.96M | 28.60M | 25.52M | 31.87M | 32.37M |
Cash Flow | ||||||
| Free Cash Flow | -71.28M | -37.50M | 1.79M | -6.28M | -1.98M | -3.08M |
| Operating Cash Flow | -28.05M | -9.69M | 2.22M | -4.75M | -249.28K | -2.43M |
| Investing Cash Flow | -81.14M | -87.40M | -42.07K | -1.34M | -1.79M | -653.13K |
| Financing Cash Flow | 145.64M | 109.48M | 4.14M | -1.07M | -267.73K | 23.78M |
United States Antimony Technical Analysis
Negative
5.20
Price Trends
4.37
Negative
5.42
Negative
7.34
Negative
Market Momentum
-0.44
Negative
28.87
Positive
44.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UAMY, the sentiment is Negative. The current price of 5.2 is above the 20-day moving average (MA) of 3.46, above the 50-day MA of 4.37, and below the 200-day MA of 7.34, indicating a bearish trend. The MACD of -0.44 indicates Negative momentum. The RSI at 28.87 is Positive, neither overbought nor oversold. The STOCH value of 44.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UAMY.
United States Antimony Risk Analysis
United States Antimony disclosed 59 risk factors in its most recent earnings report. United States Antimony reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
United States Antimony Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $1.54B | 5.57 | 25.68% | 1.15% | 23.37% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | $723.15M | -17.95 | -5.64% | 1.52% | -8.54% | 61.49% | |
50 Neutral | $426.56M | -23.50 | -12.37% | ― | 35.89% | -1309.41% | |
47 Neutral | $183.85M | -2.23 | -64.63% | ― | 406.77% | 3.36% | |
43 Neutral | $422.96M | -5.10 | -13.82% | ― | ― | 99.00% |
* Basic Materials Sector Average
UAMY
United States Antimony
2.85
-6.29
-68.82%
GSM
Ferroglobe
3.87
-1.08
-21.77%
NEXA
Nexa Resources SA
11.64
6.20
113.85%
NB
NioCorp Developments
2.90
-4.73
-61.99%
ABAT
American Battery Technology
1.28
-3.86
-75.10%
CRML
Critical Metals Corp
6.38
-5.62
-46.83%
United States Antimony Corporate Events
Business Operations and StrategyRegulatory Filings and Compliance
United States Antimony Completes Nolan Creek Technical Report
Positive
Oct 26, 2026
On October 26, 2026, United States Antimony Corporation reported it had completed a new SEC S-K 1300-compliant Technical Report Summary for its Nolan Creek Property in northern Alaska, following an amendment dated September 15, 2026 to an earlier ...
Business Operations and StrategyExecutive/Board Changes
United States Antimony Appoints Shawn Winkler Permanent CFO
Positive
Oct 2, 2026
United States Antimony Corporation, a natural resources-focused company producing antimony and related industrial materials, operates in capital-intensive commodity markets where financial strategy and access to capital are critical to its competi...
Business Operations and StrategyExecutive/Board Changes
United States Antimony Extends CEO Employment Agreement
Positive
Oct 2, 2026
On October 1, 2026, United States Antimony Corporation approved an employment agreement with Gary C. Evans to continue as Chief Executive Officer, effective August 1, 2026, for a three-year term with a $430,000 annual base salary, performance-base...
Business Operations and Strategy
United States Antimony boosts Stibnite Hill mining output
Positive
Aug 25, 2026
United States Antimony Corporation, traded on NYSE and NYSE Texas under the ticker UAMY, is the only fully integrated antimony producer outside China and Russia, with mining and processing operations for antimony, zeolite, and precious metals in t...
Business Operations and StrategyStock Buyback
United States Antimony Announces Major Share Repurchase Program
Positive
Aug 19, 2026
United States Antimony Corporation, listed on NYSE and NYSE Texas under UAMY, is the only fully integrated antimony company outside China and Russia, mining and processing antimony, zeolite, and precious metals through facilities in Montana, Mexic...
Business Operations and StrategyFinancial Disclosures
United States Antimony Sets Date for Q2 Results
Neutral
Aug 6, 2026
On August 6, 2026, United States Antimony Corporation announced plans to release its financial and operating results for the second quarter and six months ended June 30, 2026, after U.S. markets close on Tuesday, August 11, 2026. The company sched...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.